<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="of December 2019. Since the identification of the outbreak the" exact="infection" post="quickly spread involving in one month more than 31,000"/>
 <result pre="that 2019-nCoV could be originated from bats after passaging in" exact="intermediate" post="hosts, highlighting the high zoonotic potential of coronaviruses. The"/>
 <result pre="of coronaviruses and the need of international collaboration to block" exact="viral" post="spread. coronavirus SARS MERS 2019-nCoV zoonosis page-count: CORONAVIRUSES Coronaviruses"/>
 <result pre="are important pathogens for humans and animals, usually associated to" exact="respiratory" post="and gastro-intestinal infections. CoVs are spherical enveloped viruses with"/>
 <result pre="RNA genome of 27â€&quot;32Â kb that interacts with the nucleoprotein." exact="Viral" post="envelope includes three different proteins: Membrane (M), Envelope (E)"/>
 <result pre="(S) proteins. M protein binds nucleocapsids and is involved in" exact="viral" post="assembly and budding; E protein contributes to viral morphogenesis"/>
 <result pre="involved in viral assembly and budding; E protein contributes to" exact="viral" post="morphogenesis and release as well as to pathogenesis. Finally,"/>
 <result pre="forms homotrimeric spikes that recognize the cellular receptor, thus allowing" exact="viral" post="entry into target cells (Chen, Liu and Guo 2020)."/>
 <result pre="emergence of the 2019-nCoV. Genus Virus Natural host Intermediate host" exact="Disease" post="Receptor Alphacoronavirus HCoV-NL63 Bats Unknown Mild respiratory tract infections"/>
 <result pre="host Intermediate host Disease Receptor Alphacoronavirus HCoV-NL63 Bats Unknown Mild" exact="respiratory" post="tract infections Angiotensin converting enzyme 2 HCoV-229E Bats Camelids"/>
 <result pre="host Disease Receptor Alphacoronavirus HCoV-NL63 Bats Unknown Mild respiratory tract" exact="infections" post="Angiotensin converting enzyme 2 HCoV-229E Bats Camelids Mild respiratory"/>
 <result pre="tract infections Angiotensin converting enzyme 2 HCoV-229E Bats Camelids Mild" exact="respiratory" post="tract infections Human aminopeptidase N Betacoronavirus HCoV-OC43 Rodents Bovine"/>
 <result pre="Angiotensin converting enzyme 2 HCoV-229E Bats Camelids Mild respiratory tract" exact="infections" post="Human aminopeptidase N Betacoronavirus HCoV-OC43 Rodents Bovine Mild respiratory"/>
 <result pre="Mild respiratory tract infections Human aminopeptidase N Betacoronavirus HCoV-OC43 Rodents" exact="Bovine" post="Mild respiratory tract infections 9-O-acetylsialic acids HCoV-HKU1 Rodents Unknown"/>
 <result pre="tract infections Human aminopeptidase N Betacoronavirus HCoV-OC43 Rodents Bovine Mild" exact="respiratory" post="tract infections 9-O-acetylsialic acids HCoV-HKU1 Rodents Unknown Mild respiratory"/>
 <result pre="Human aminopeptidase N Betacoronavirus HCoV-OC43 Rodents Bovine Mild respiratory tract" exact="infections" post="9-O-acetylsialic acids HCoV-HKU1 Rodents Unknown Mild respiratory tract infections"/>
 <result pre="Mild respiratory tract infections 9-O-acetylsialic acids HCoV-HKU1 Rodents Unknown Mild" exact="respiratory" post="tract infections and pneumonia 9-O-acetylsialic acids SARS-CoV Bats Masked"/>
 <result pre="tract infections 9-O-acetylsialic acids HCoV-HKU1 Rodents Unknown Mild respiratory tract" exact="infections" post="and pneumonia 9-O-acetylsialic acids SARS-CoV Bats Masked palmes civetes"/>
 <result pre="9-O-acetylsialic acids HCoV-HKU1 Rodents Unknown Mild respiratory tract infections and" exact="pneumonia" post="9-O-acetylsialic acids SARS-CoV Bats Masked palmes civetes Severe acute"/>
 <result pre="infections and pneumonia 9-O-acetylsialic acids SARS-CoV Bats Masked palmes civetes" exact="Severe" post="acute respiratory syndrome Angiotensin converting enzyme 2 MERS-CoV Bats"/>
 <result pre="and pneumonia 9-O-acetylsialic acids SARS-CoV Bats Masked palmes civetes Severe" exact="acute" post="respiratory syndrome Angiotensin converting enzyme 2 MERS-CoV Bats Camelids"/>
 <result pre="pneumonia 9-O-acetylsialic acids SARS-CoV Bats Masked palmes civetes Severe acute" exact="respiratory" post="syndrome Angiotensin converting enzyme 2 MERS-CoV Bats Camelids Severe"/>
 <result pre="9-O-acetylsialic acids SARS-CoV Bats Masked palmes civetes Severe acute respiratory" exact="syndrome" post="Angiotensin converting enzyme 2 MERS-CoV Bats Camelids Severe acute"/>
 <result pre="acute respiratory syndrome Angiotensin converting enzyme 2 MERS-CoV Bats Camelids" exact="Severe" post="acute respiratory syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe"/>
 <result pre="respiratory syndrome Angiotensin converting enzyme 2 MERS-CoV Bats Camelids Severe" exact="acute" post="respiratory syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe acute"/>
 <result pre="syndrome Angiotensin converting enzyme 2 MERS-CoV Bats Camelids Severe acute" exact="respiratory" post="syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe acute respiratory"/>
 <result pre="Angiotensin converting enzyme 2 MERS-CoV Bats Camelids Severe acute respiratory" exact="syndrome" post="Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe acute respiratory syndrome"/>
 <result pre="Camelids Severe acute respiratory syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown" exact="Severe" post="acute respiratory syndrome Angiotensin converting enzyme 2 Until 2002,"/>
 <result pre="Severe acute respiratory syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe" exact="acute" post="respiratory syndrome Angiotensin converting enzyme 2 Until 2002, CoVs"/>
 <result pre="acute respiratory syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe acute" exact="respiratory" post="syndrome Angiotensin converting enzyme 2 Until 2002, CoVs were"/>
 <result pre="respiratory syndrome Dipeptidyl peptidase-4 2019-nCoV Bats Unknown Severe acute respiratory" exact="syndrome" post="Angiotensin converting enzyme 2 Until 2002, CoVs were considered"/>
 <result pre="pathogens for humans, generally associated to common cold or mild" exact="respiratory" post="infections in immunocompetent people, with rare exceptions represented by"/>
 <result pre="for humans, generally associated to common cold or mild respiratory" exact="infections" post="in immunocompetent people, with rare exceptions represented by severe"/>
 <result pre="infections in immunocompetent people, with rare exceptions represented by severe" exact="infections" post="in infants, young children and elder people (Channappanavar and"/>
 <result pre="with the emergence of a highly pathogenic zoonotic disease, the" exact="Severe" post="Acute Respiratory Syndrome (SARS) caused by the SARS-CoV. SARS"/>
 <result pre="the emergence of a highly pathogenic zoonotic disease, the Severe" exact="Acute" post="Respiratory Syndrome (SARS) caused by the SARS-CoV. SARS mainly"/>
 <result pre="emergence of a highly pathogenic zoonotic disease, the Severe Acute" exact="Respiratory" post="Syndrome (SARS) caused by the SARS-CoV. SARS mainly presented"/>
 <result pre="of a highly pathogenic zoonotic disease, the Severe Acute Respiratory" exact="Syndrome" post="(SARS) caused by the SARS-CoV. SARS mainly presented as"/>
 <result pre="in the field suggested that masked palm civets functioned as" exact="intermediate" post="hosts between an unknown animal reservoir and humans. In"/>
 <result pre="These findings support the hypothesis that bats represent the main" exact="viral" post="reservoir for CoVs and that SARS-CoVs originated from bats."/>
 <result pre="the gene encoding for the S protein, that determines the" exact="viral" post="tropism and host spectrum, shows a high level of"/>
 <result pre="of variability on the receptor binding domain, an indication of" exact="viral" post="adaptation in the different bats species and other animal"/>
 <result pre="(ACE2), the human receptor adopted by the SARS-CoV to infect" exact="epithelial" post="cells in the lower respiratory tract. This observation suggests"/>
 <result pre="adopted by the SARS-CoV to infect epithelial cells in the" exact="lower" post="respiratory tract. This observation suggests that new spillover events,"/>
 <result pre="by the SARS-CoV to infect epithelial cells in the lower" exact="respiratory" post="tract. This observation suggests that new spillover events, from"/>
 <result pre="the specie barrier. As expected, in addition to S, other" exact="viral" post="genes (such as orf8) can mutate during the viral"/>
 <result pre="other viral genes (such as orf8) can mutate during the" exact="viral" post="adaptation to the new host, as reported for the"/>
 <result pre="genome of different CoVs. Therefore, the ability to originate new" exact="viral" post="variants can promote jumps from bats to other sylvatic"/>
 <result pre="domestic animals or humans (Cui, Li and Shi 2019). A" exact="total" post="of 10 years after the onset of SARS outbreak"/>
 <result pre="jumped from animals to humans causing the lethal Middle East" exact="Respiratory" post="Syndrome (MERS) (WHO 2020b). The new emerging disease was"/>
 <result pre="from animals to humans causing the lethal Middle East Respiratory" exact="Syndrome" post="(MERS) (WHO 2020b). The new emerging disease was first"/>
 <result pre="Middle East Respiratory Syndrome (MERS) (WHO 2020b). The new emerging" exact="disease" post="was first identified in humans in 2012 and interested"/>
 <result pre="active and sporadic outbreaks have been reported until now. This" exact="respiratory" post="disease is particularly severe, accounting for 2465 cases confirmed"/>
 <result pre="and sporadic outbreaks have been reported until now. This respiratory" exact="disease" post="is particularly severe, accounting for 2465 cases confirmed by"/>
 <result pre="or camel products (Chan etÂ al.2015). The origin of human" exact="infections" post="through the camelids is demonstrated by virus neutralization experiments"/>
 <result pre="camelids is demonstrated by virus neutralization experiments and by the" exact="viral" post="genomic sequence analyses. Interestingly, MERS-CoV- like viruses have been"/>
 <result pre="of December 2019 the news of an outbreak of a" exact="respiratory" post="disease of unknown aetiology in Wuhan city, Hubei province"/>
 <result pre="December 2019 the news of an outbreak of a respiratory" exact="disease" post="of unknown aetiology in Wuhan city, Hubei province of"/>
 <result pre="cough and difficulties in breathing, with an evolution to severe" exact="pneumonia" post="in the most severe cases. After few days from"/>
 <result pre="are frequent in elderly, in people with comorbidity, and that" exact="infection" post="involve mainly adults (Huang etÂ al.2020; Li etÂ al.2020)."/>
 <result pre="Commission in Wuhan City, China, reports a cluster of 27" exact="pneumonia" post="cases of unknown aetiology, 7 Jan 2020 Identification of"/>
 <result pre="detected as the causative agent for 15 of the 59" exact="pneumonia" post="cases 10 Jan 2020 First 2019-nCoV genome sequence was"/>
 <result pre="was made publicly available 13 Jan 2020 First case of" exact="infection" post="outside of China (1 imported case in Thailand) 21"/>
 <result pre="Wuhan (Nishiura etÂ al.2020). Furthermore, the original source of the" exact="infection" post="and the specific association with animal hosts have not"/>
 <result pre="to humans probably after the passage in one or more" exact="intermediate" post="hosts (Lu etÂ al.2020). Recent data on 2019-nCoV molecular"/>
 <result pre="Recent data on 2019-nCoV molecular evolution suggest that two different" exact="viral" post="strains of 2019-nCoV are involved in the outbreak and"/>
 <result pre="aspect of developing effective prophylactic and/or therapeutic interventions to control" exact="infection" post="and/or spreading of this novel CoV. So far, treatments"/>
 <result pre="Ritonavir are known anti-retroviral drug targeting protease of the human" exact="immunodeficiency" post="virus (HIV). However, CoVs are characterized by a 3C-like"/>
 <result pre="their efficacy is not expected to be sufficient to control" exact="viral infection." post="Recently, Wang and co-workers reported that Remdesivir, a nucleotide"/>
 <result pre="prodrug initially developed for the treatment of Ebola and Marburg" exact="virus infection," post="and the anti-malarial drug chloroquine are effective to inhibit"/>
 <result pre="Goo etÂ al.2020). Many monoclonal antibodies neutralizing SARS-CoV and MERS-CoV" exact="infections" post="have been identified, and some of them displayed a"/>
 <result pre="has been shown that antibody administration fully protected mice from" exact="viral" post="challenges (Jin etÂ al.2017). Thus, as reported for Ebola"/>
 <result pre="virus, the use of monoclonal antibodies to treat severe CoVs" exact="infections" post="could be a promising strategy (Jin etÂ al.2017). In"/>
 <result pre="characterization of the virome of different animals to study the" exact="viral" post="evolution and adaptation to their natural hosts (Holmes, Rambaut"/>
 <result pre="new molecular/bioinformatics technologies with the classical virological techniques applied to" exact="viral" post="models can provide knowledge to prevent new dangerous spillover"/>
 <result pre="of infection. In this regard, the possibility to rapidly sequence" exact="viral" post="genomes combined with synthetic biology approaches, could speed up"/>
 <result pre="However, it has to be kept in mind that while" exact="viral" post="isolation, along with technological advances, might allow the rapid"/>
 <result pre="and more efforts on a global preparedness/response system against emerging" exact="infectious diseases" post="are absolutely mandatory. FUNDING This work received no external"/>
 <result pre="infectious diseases are absolutely mandatory. FUNDING This work received no" exact="external" post="funding. Conflicts of interest None declared. References REFERENCES ChannappanavarR,"/>
 <result pre="and immunopathology. Semin Immunopathol. 2017;39:529â€&quot;39.28466096 ChanJF, LauSKP, ToKKWet al..Middle East" exact="respiratory" post="syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin"/>
 <result pre="immunopathology. Semin Immunopathol. 2017;39:529â€&quot;39.28466096 ChanJF, LauSKP, ToKKWet al..Middle East respiratory" exact="syndrome" post="coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol"/>
 <result pre="SARS-like disease. Clin Microbiol Rev. 2015;28:465â€&quot;522.25810418 ChanJF, YuanS, KokKHet al..A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="Microbiol Rev. 2015;28:465â€&quot;522.25810418 ChanJF, YuanS, KokKHet al..A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="ParkKet al..Selection and characterization of monoclonal antibodies targeting middle east" exact="respiratory" post="syndrome coronavirus through a human synthetic fab phage display"/>
 <result pre="al..Selection and characterization of monoclonal antibodies targeting middle east respiratory" exact="syndrome" post="coronavirus through a human synthetic fab phage display library"/>
 <result pre="pii: E42. KuikenT, FouchierRA, SchuttenMet al..Newly discovered coronavirus as the" exact="primary" post="cause of severe acute respiratory syndrome. Lancet. 2003;362:263â€&quot;70.12892955 KupferschmidtKStudy"/>
 <result pre="SchuttenMet al..Newly discovered coronavirus as the primary cause of severe" exact="acute" post="respiratory syndrome. Lancet. 2003;362:263â€&quot;70.12892955 KupferschmidtKStudy claiming new coronavirus can"/>
 <result pre="al..Newly discovered coronavirus as the primary cause of severe acute" exact="respiratory" post="syndrome. Lancet. 2003;362:263â€&quot;70.12892955 KupferschmidtKStudy claiming new coronavirus can be"/>
 <result pre="Accessed 3 February 2020. RotheC, SchunkM, SothmannPet al..Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in Germany. N Engl J"/>
 <result pre="(2019-nCoV) in vitro. Cell Res. 2020; doi: 10.1038/s41422-020-0282-0. collab: WHO2020aSevere" exact="Acute" post="Respiratory Syndrome (SARS). https://www.who.int/csr/sars/en/. Accessed 2 February 2020. collab:"/>
 <result pre="in vitro. Cell Res. 2020; doi: 10.1038/s41422-020-0282-0. collab: WHO2020aSevere Acute" exact="Respiratory" post="Syndrome (SARS). https://www.who.int/csr/sars/en/. Accessed 2 February 2020. collab: WHO2020bMiddle"/>
 <result pre="vitro. Cell Res. 2020; doi: 10.1038/s41422-020-0282-0. collab: WHO2020aSevere Acute Respiratory" exact="Syndrome" post="(SARS). https://www.who.int/csr/sars/en/. Accessed 2 February 2020. collab: WHO2020bMiddle East"/>
 <result pre="Syndrome (SARS). https://www.who.int/csr/sars/en/. Accessed 2 February 2020. collab: WHO2020bMiddle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1. Accessed 2 February 2020. collab:"/>
 <result pre="(SARS). https://www.who.int/csr/sars/en/. Accessed 2 February 2020. collab: WHO2020bMiddle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1. Accessed 2 February 2020. collab: WHO2020cStatement"/>
 <result pre="BestebroerTMet al..Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia. N Engl J Med. 2012;367:1814â€&quot;20.23075143 ZhouP,"/>
 <result pre="Arabia. N Engl J Med. 2012;367:1814â€&quot;20.23075143 ZhouP, YangXL, WangXGet al..A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="10.1038/s41586-020-2012-7. ZhuN, ZhangD, WangWet al..A Novel Coronavirus from Patients with" exact="Pneumonia" post="in China, 2019. N Engl J Med. 2020; doi:"/>
</results>
